Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 7.90
+0.17 (2.20%)
Apr 25, 2025, 5:29 PM CET
Diamyd Medical AB Revenue
Diamyd Medical AB had revenue of 86.00K SEK in the quarter ending February 28, 2025, with 230.77% growth. This brings the company's revenue in the last twelve months to 182.00K, down -35.46% year-over-year. In the fiscal year ending August 31, 2024, Diamyd Medical AB had annual revenue of 130.00K, down -76.19%.
Revenue (ttm)
182.00K
Revenue Growth
-35.46%
P/S Ratio
4,518.11
Revenue / Employee
6.07K
Employees
28
Market Cap
822.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 130.00K | -416.00K | -76.19% |
| Aug 31, 2023 | 546.00K | 92.00K | 20.26% |
| Aug 31, 2022 | 454.00K | 201.00K | 79.45% |
| Aug 31, 2021 | 253.00K | -88.00K | -25.81% |
| Aug 31, 2020 | 341.00K | -1.23M | -78.25% |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |
| Vitrolife AB | 3.61B |